onded the need for reliable authentication methods for pharmaceuticals. She noted that some of the countries most affected by the problem are beginning to address counterfeiting and are placing greater emphasis on drug quality. Hale has observed that when poor people are very sick and fear they may die, they ask for injections instead of oral products because in their experience, oral products are of poor quality. This is why OneWorld Health developed an injectable intramuscular paromomycin for visceral leishmaniasis. Corr cited two approaches to the problems of counterfeiting and reimportation currently being used by pharmaceutical companies: manufacturing pills that are shipped to developing countries in a different color, which decreases the pills’ reimportation into the developed world, and radiofrequency identification tagging, which can now be done on a capsule or ampule.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement